Characterization & Treatment of Chronic Pain After Moderate to Severe TBI
NCT ID: NCT03739307
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3805 participants
OBSERVATIONAL
2019-05-20
2022-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain
NCT03003715
Neuroimaging of Pain: Changes in Regional Brain Functioning Associated With Amplified Pain and Intensive Treatment
NCT03703921
REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
NCT03504709
The Use of Resting State, fMRI and DTI in the Identification of Chronic Pain Conditions
NCT02987933
Evaluation and Diagnosis of Potential Research Subjects With Traumatic Brain Injury
NCT01287156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Results from this study will provide a more detailed picture of the problem of chronic pain after TBI by examining the types of pain that occur after TBI, which may be multiple types of pain for a subset of individuals, as well as the frequency of comorbid conditions. Identifying extreme phenotypes, such as demographic, individual, and treatment factors associated with those who have chronic pain but have minimal interference compared to those who are significantly impacted by pain, will allow us to identify treatment targets (behavioral, cognitive, biological, and molecular) to advance a personalized medicine approach to treatment unlike any approach in TBI and chronic pain to date. Outcomes from this study will include educational materials on chronic pain and pain treatment to benefit patients, family members, clinicians, and policymakers. Data from this study will have a direct impact on clinical practice, informing future work, and promoting understanding of constituent factors in extreme phenotypes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
James A. Haley Veterans Administration Hospital
FED
Rehabilitation Hospital of Indiana
OTHER
Spaulding Rehabilitation Hospital
OTHER
Wayne State University
OTHER
Mayo Clinic
OTHER
Baylor Institute for Rehabilitation
OTHER
Virginia Commonwealth University
OTHER
NYU Langone Health
OTHER
University of Alabama at Birmingham
OTHER
Moss Rehabilitation Research Institute
OTHER
TIRR Memorial Hermann
OTHER
Craig Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cynthia Harrison-Felix, PhD
Co-Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama
Birmingham, Alabama, United States
Craig Hospital
Englewood, Colorado, United States
Tampa VA
Tampa, Florida, United States
Indiana University
Indianapolis, Indiana, United States
Spaulding Rehabilitation Institute
Charlestown, Massachusetts, United States
Wayne State University
Detroit, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
New York University School of Medicine
New York, New York, United States
MOSS Rehabilitation Research Institute
Elkins Park, Pennsylvania, United States
Baylor Research Institute
Dallas, Texas, United States
TIRR Memorial Hermann
Houston, Texas, United States
Virginia Commonwealth University
Richmond, Virginia, United States
University of Washington
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
90DPTB0017-01-00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.